ࡱ> %("#$ d6bjbjҰҰ d. BBBBBVVVVllVD%0.(VVVV $$$$$$$$t&&)b$B I @ $BBVV$$$$ BVBV$$ $$$$VPe K'# $$%0D%$)1#)$)B$ $ $$$ D% ) : General Restrictions for OTC Sale Consult individual summary of product characteristic for full product information. All OTC restrictions have been completed to the best of our knowledge and further advice can be obtained at the point of purchase during the pharmacy consultation. ConditionCircumstances when not suitable for OTC saleAcute sore throatsIbuprofen long term conditions requiring regular pain relief, asthma, unstable high blood pressure, taking anticoagulants, stomach ulcer, perforation or bleeding (active or history of), renal, hepatic or cardiac impairment, pregnancy, breastfeeding, children under 3 months and not for use in chicken poxParacetamol - long term conditions requiring regular pain relief, severe renal or severe hepatic impairment, children under 2 months, babies born before 37 weeks and babies weighing less than 4kgInfrequent cold sores of the lipAciclovir cream 5% - Immunocompromised and terminally ill. Only to be applied to face and lipsConjunctivitisChloramphenicol 0.5% eye drops & 1% eye ointment children under 2 years, pregnancy and breastfeeding. Not suitable for other ocular infections.Coughs, colds, nasal congestionsIbuprofen long term conditions requiring regular pain relief, asthma, unstable high blood pressure, taking anticoagulants, stomach ulcer, perforation or bleeding (active or history of), renal, hepatic or cardiac impairment, pregnancy, breastfeeding, children under 3 months and not for use in chicken poxParacetamol long term conditions requiring regular pain relief, severe renal or severe hepatic impairment, children under 2 months, babies born before 37 weeks and babies weighing less than 4kg Pseudoephedrine (Sudafed) tablets not suitable for children under 12 years, liquid not suitable for children under 6 years, pregnancy, breastfeeding, hypertension, severe coronary artery disease, severe renal impairment, phaeochromocytoma, diabetes, hyperthyroidism and closed angle glaucomaCradle capOlive oil, baby oil, emulsifying ointments and shampoos not to be used on broken or infected skin or if it has spread to the faceHaemorrhoidsZinc oxide haemorrhoid products children under 18 years, pregnancy, breastfeeding, rectal bleeding or blood in the stoolInfant colicDimeticone 42mg/5ml infant drops (Dentinox Infant Colic Drop) should be avoided in fructose, glucose-galactose or sucrose intolerant patients as it contains sucroseMild cystitisSodium citrate 4g sachet products men, children under 16 years, diabetes, heart disease, hypertension, renal disease, pregnancy and breastfeedingPotassium citrate products children under 6 years, history of renal disease pregnancy and breastfeedingMild irritant dermatitisAll products broken or inflamed skinSteroid creams pregnancy, breastfeeding, for children under 10 years and not for use on the eyes, face or ano-genital region Emollients see section on mild dry skinDandruffAll products pregnancy and breastfeedingKetoconazole shampoo (Nizoral) children under 12 yearsCoal tar shampoo (Polytar Scalp Shampoo) children under 12 years, infected open skin lesions and sore or acute pustular psoriasisSelenium sulfide shampoo (Selsun) children under 5 yearsDiarrhoea (acute) (adults only)All products - pharmacy to refer to GP for chronic or persistent diarrhoeaOral rehydration sachets patients with liver or renal disease, patients on low potassium/sodium diets and patients with diabetesLoperamide inflammatory bowel disease, post bowel surgery, post pelvic radiation, colorectal cancer and children under 12 years oldDry eyes/sore tired eyesLubricant eye treatments - pregnancy, breastfeeding and contact lensesEarwaxNo restrictionsExcessive sweatingNo restrictionsHeadliceAll products children under 6 monthsIndigestion and heartburnAll products pregnancy, breastfeeding, jaundice or liver diseaseGaviscon - children under 12 years, renal failure, hypercalcaemia, nephrocalcinosis, kidney stonesGaviscon Infant children under 12 months and children over 2 years, babies born before 37 weeks and in renal impairmentEsomeprazole and pantoprazole children under 18 years or adults over 55 years with new or recently changed symptoms. Only suitable for occasional useRanitidine children under 16 years, peptic ulceration or elderly taking NSAIDS. Only suitable for occasional use.Infrequent constipationLactulose galactosaemia, gastro-intestinal obstruction, digestive perforation or risk of digestive perforationBisacodyl acute inflammatory bowel diseases, severe dehydration, pregnancy and breastfeeding and children under 12 yearsSenna severe dehydration, children under 12 years, pregnancy and breastfeedingIspaghula Husk Granules children under 6 years and diabetesInfrequent migraineIbuprofen long term conditions requiring regular pain relief, asthma, unstable high blood pressure, taking anticoagulants, stomach ulcer, perforation or bleeding (active or history of), renal, hepatic or cardiac impairment, pregnancy, breastfeeding and children under 12 yearsParacetamol long term conditions requiring regular pain relief, severe renal or severe hepatic impairment, children under 2 months, babies born before 37 weeks and babies weighing less than 4kgProchlorperazine maleate patients under 18 years old, impaired liver function, existing blood dyscrasias, epilepsy, Parkinsons disease, prostatic hypertrophy, narrow angle glaucoma, pregnancy and breastfeedingSumatriptan 50mg tablets people who have 4 or more attacks per month, atypical symptoms, aged under 18 or over 65 years, headaches that last >24 hours, pregnant or breastfeedingInsect bites and stingsMepyramine maleate 2% (Anthisan Bite and Sting Cream 2%) children under 2 years, pregnancy and breastfeedingSavlon Bites and Stings Pain Relief Gel children under 12 yearsMild acneBenzoyl peroxide-containing preparation pregnancy, breastfeeding, damaged skin and children under 12 yearsMild dry skinAll Emollients broken or infected skinAveeno Cream and lotion babies under 3 month oldsE45 for children lotion babies under 1 month oldCetraban Cream and lotion babies under 1 year oldsSunburnNo restrictionsSun protectionNo restrictionsHayfever / allergic rhinitisCetirizine tablets children under 6 years, 1mg/ml solution children under 2 years, epilepsy, renal impairment, rare hereditary problems of fructose intolerance, pregnancy and breastfeedingLoratadine tablets children under 6 years, 1mg/ml syrup children under 2 years, rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption, liver impairment, pregnancy and breastfeedingChlorphenamine tablets children under 6 years, 2mg/5ml solution children under 1 year. Not within 14 days of taking a monoamine oxidase inhibitors, epilepsy, raised intra-ocular pressure including glaucoma, prostatic hypertrophy, hypertension or cardiovascular disease, bronchitis, bronchiectasis or asthma, hepatic impairment, renal impairment, rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption, pregnancy and breastfeeding. Not to be used continuously for more than two weeks without consulting a doctor and avoid use in elderly patients with confusion.Acrivastine children under 12 years and adults over 65 years, renal impairment, rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption, pregnancy and breastfeedingBeclomethasone 0.05% nasal spray children under 18 years, pregnancy and breastfeeding. For up to three months continuous use during allergy season for OTCSodium cromoglicate 2% eye drops - children under 6 years, pregnancy and breastfeedingMinor burns and scaldsNo restrictionsMinor conditions associated with painIbuprofen long term conditions requiring pain relief, asthma, unstable high blood pressure, severe renal or severe hepatic impairment, taking anticoagulants, stomach ulcers/problems, children under 3 months, pregnancy, breastfeeding and not for use in chicken poxParacetamol long term conditions requiring pain relief, severe renal or severe hepatic impairment, children under 2 months, babies born before 37 weeks and babies weighing less than 4kgCo-codamol children under 12 years, severe liver disease, breastfeeding and pregnancy. Maximum of three days treatment for OTC due to risk of addictionMouth ulcersAll products pregnancy and breastfeedingCholine salicylate/cetalkonium chloride (Bonjela) children under 16 years, active peptic ulcerationLidocaine hydrochloride/chlorocresol cetylpyridinium chloride (Anbesol) children under 5 monthsBenzocaine (Orajel Mouth gel) children under 12 yearsNappy rashNo restrictionsOral thrushMiconazole 2% oral gel (Daktarin oral gel) children under 4 months, pregnancy, breastfeeding, liver dysfunction, patients taking warfarin and statinsPrevention of dental cariesChlorhexidine digluconate mouthwashes children under 12 yearsRingworm / athletes footAll products diabetic patients, pregnancy and breastfeedingTerbinafine hydrochloride 1% - children under 16 yearsTeething / mild toothacheIbuprofen long term conditions requiring regular pain relief, asthma, unstable high blood pressure, taking anticoagulants, stomach ulcer, perforation or bleeding (active or history of), renal, hepatic or cardiac impairment, pregnancy, breastfeeding, children under 3 months and not for use in chicken poxParacetamol long term conditions requiring regular pain relief, severe renal or severe hepatic impairment, children under 2 months, babies born before 37 weeks and babies weighing less than 4kgDentinox Teething Gel babies under 5 monthsBonjela Teething Gel babies under 5 months, heart disease and liver diseaseThreadwormsMebendazole 100mg tablets children under 2 years, pregnancy and breastfeedingTravel sicknessCinnarizine tablets 15mg (Stugeron) Parkinsons, people with fructose or galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption or sucrose-isomaltase insufficiency should not take this medicine because it contains lactose and sucrose, porphyria, children under 5 years, pregnancy and breastfeeding. Not suitable for any other causes of nausea or dizziness for OTC.Hyoscine hydrobromide tablets 150mcg (Joyrides and Kwells) children under 3 years for Joyriders brand under 4 years for Kwells brand, epilepsy, glaucoma, pregnancy, breastfeeding, paralytic ileus, pyloric stenosis/prostatic enlargement, myasthenia gravisWarts and verrucaeVerruca gels and wart paint/ointment containing salicyclic acid and lactic acid diabetic patients, impaired peripheral blood circulation, not for use on face, neck, ano-genital area, moles, birthmarks, hair warts or skin lesions and broken skinWart freeze treatments (Scholl Freeze and Bazuka Subzero) as above but also including children under 4 years Reference and acknowledgements Electronic Medicines Compendium (emC): Directory of prescribing and patient information for licensed medicines. Available at:  HYPERLINK "https://www.medicines.org.uk/emc/" https://www.medicines.org.uk/emc/ - Last accessed 18/09/2020 PrescQIPP: Self-Care and over-the-counter items. Available at:  HYPERLINK "https://www.prescqipp.info/media/4056/227-self-care-and-otc-items-quick-reference-guide-24.pdf - Last accessed 18/09/2020" https://www.prescqipp.info/media/4056/227-self-care-and-otc-items-quick-reference-guide-24.pdf - Last accessed 18/09/2020 Last updated: 29/01/2021 By: SLS Planned Review: November 2021 Approved: 20/021/2021 By: NY/VoYMMB #$%  S T p b c õwbP?b?P?.?b h.iheCJOJQJ^JaJ h.ihfCJOJQJ^JaJ#h.ihf5CJOJQJ^JaJ)h.ihfB*CJOJQJ^JaJph,h.ihf5B*CJOJQJ^JaJph)hfhfB*CJOJQJ^JaJph#hfB*CJOJQJ^JaJphhfCJOJQJ^JaJh%CJOJQJ^JaJ&hfhf5>*CJOJQJ^JaJ4jhfhfCJOJQJU^JaJmHnHu$% & S T g _kd$$Ifl0Vn*%    tI}I}0+644 lapI}I}yt.i$If b c]]$Ifkd$$Ifl4K0Vn*`% @@ t0+644 lapyt.ib c c]]]$Ifkd$$Ifl4K0Vn* % @@ t0+644 lapyt.ic $ [ \ ʹʹʤʖpp__pM#h.ihA5CJOJQJ^JaJ h.ihACJOJQJ^JaJ)h.iheB*CJOJQJ^JaJph h5Nh^ACJOJQJ^JaJh^ACJOJQJ^JaJ)h.ihfB*CJOJQJ^JaJph h.ihfCJOJQJ^JaJ h.iheCJOJQJ^JaJ#h.ihe5CJOJQJ^JaJ#h.ihf5CJOJQJ^JaJ \ gaaa$Ifkd^$$Ifl0Vn*% @@ t0+644 lapyt.i gaa$Ifkd $$Ifl0Vn*% @@ t0+644 lapyt.i c]]$Ifkd$$Ifl40Vn*`% @@ t0+644 lapyt.ic]]$Ifkd$$Ifl40Vn* % @@ t0+644 lapyt.i\c]]$Ifkd~$$Ifl40Vn* % @@ t0+644 lapyt.i[\]ij1>?Z7;X˶˶˶܏܏܏pbhgaa$Ifkd$$Ifl0Vn*% @@ t0+644 lapyt.i>?@c]]$Ifkd$$Ifl4K0Vn*`% @@ t0+644 lapyt.ic]]$Ifkd` $$Ifl4K0Vn* % @@ t0+644 lapyt.ilc]T $Ifgd^A$Ifkd. $$Ifl4e0Vn*`% @@ t0+644 lapyt.iXklmnx  4;<U4HIabzɷɥqqqqqqcqhuvXƴ괢Ƣꢴr]HH)h.ihXB*CJOJQJ^JaJph)h.iha=?B*CJOJQJ^JaJph h.iha=?CJOJQJ^JaJ h.ihXCJOJQJ^JaJh^ACJOJQJ^JaJ#h.ihX5CJOJQJ^JaJ#h.iha=?5CJOJQJ^JaJ#h.ihA5CJOJQJ^JaJ#h.ih5CJOJQJ^JaJ)h.ihAB*CJOJQJ^JaJphgaX $IfgdrQ?$Ifkd$$Ifl0Vn*% @@ t0+644 lapyt.igaa$Ifkd$$Ifl0Vn*% @@ t0+644 lapyt.i2ugaa$Ifkd$$Ifl0Vn*% @@ t0+644 lapyt.iuvwc]]$IfkdN$$Ifl40Vn*`% @@ t0+644 lapyt.iXc]]$Ifkd$$Ifl40Vn* % @@ t0+644 lapyt.iXYZc]]$Ifkd$$Ifl40Vn* % @@ t0+644 lapyt.iXYZwghiopv -./0;ƵƵƵƵƵƵ}l}l}l}l h.ih1PCJOJQJ^JaJ#h.ih1P5CJOJQJ^JaJ)h.ih 7B*CJOJQJ^JaJph h.ihXCJOJQJ^JaJ h.ih 7CJOJQJ^JaJ#h.ih 75CJOJQJ^JaJ#h.ihX5CJOJQJ^JaJ)h.ihXB*CJOJQJ^JaJph*hc]]$Ifkd$$Ifl40Vn* % @@ t0+644 lapyt.ihic]]$Ifkd$$Ifl40Vn* % @@ t0+644 lapyt.ioc]]$IfkdT$$Ifl4L0Vn*`% @@ t0+644 lapyt.iopqc]]$Ifkd"$$Ifl4K0Vn* % @@ t0+644 lapyt.ic]]$Ifkd$$Ifl4K0Vn* % @@ t0+644 lapyt.i.c]]$Ifkd$$Ifl4K0Vn* % @@ t0+644 lapyt.i./0c]]$Ifkd$$Ifl4L0Vn*`% @@ t0+644 lapyt.ic]]$IfkdZ$$Ifl4K0Vn* % @@ t0+644 lapyt.ic]]$Ifkd($$Ifl4K0Vn* % @@ t0+644 lapyt.i c]]$Ifkd$$Ifl4K0Vn* % @@ t0+644 lapyt.i  5PQZ[   $ 6 7 8 9 P [ l m n o DzDzؠǏDz؁pDz^pDz^pDz^^#h.ihy\5CJOJQJ^JaJ h.ihy\CJOJQJ^JaJh^ACJOJQJ^JaJ h.ih 7CJOJQJ^JaJ#h.ih 75CJOJQJ^JaJ)h.ih1PB*CJOJQJ^JaJph h.ih1PCJOJQJ^JaJ#h.ih1P5CJOJQJ^JaJ)h.ih 7B*CJOJQJ^JaJph$   Pc]]$Ifkd$$Ifl40Vn*`% @@ t0+644 lapyt.iPQ[c]]$Ifkd $$Ifl40Vn* % @@ t0+644 lapyt.i gaa$Ifkd`!$$Ifl0Vn*% @@ t0+644 lapyt.i   7 c]]$Ifkd""$$Ifl4'0Vn*`% @@ t0+644 lapyt.i7 8 9 m c]]$Ifkd"$$Ifl4%0Vn* % @@ t0+644 lapyt.im n o c]]$Ifkd#$$Ifl4%0Vn* % @@ t0+644 lapyt.i c]]$Ifkd$$$Ifl4%0Vn* % @@ t0+644 lapyt.i !!!!!9!!!!!!!""""""#$%%%%ƷƨtƚtƚcUthB/CJOJQJ^JaJ h.ihCJOJQJ^JaJ)h.ihy\B*CJOJQJ^JaJph h.ihy\CJOJQJ^JaJh^ACJOJQJ^JaJh^A5CJOJQJ^JaJh- 5CJOJQJ^JaJ#h.ihy\5CJOJQJ^JaJ)h.ih 7B*CJOJQJ^JaJph#h.ih 75CJOJQJ^JaJ gaa$IfkdZ%$$Ifl0Vn*% @@ t0+644 lapyt.i !gaa$Ifkd&$$Ifl0Vn*% @@ t0+644 lapyt.i!!!"c]]$Ifkd&$$Ifl40Vn*`% @@ t0+644 lapyt.i"""%c]]$Ifkd'$$Ifl40Vn* % @@ t0+644 lapyt.i%%%%c]]$Ifkdz($$Ifl40Vn* % @@ t0+644 lapyt.i%)%,%%%&&!&&&&&&&&&' '''' '!'F'G'P'P(Q(ννν햨xfxXG h$]h$]CJOJQJ^JaJh$]CJOJQJ^JaJ#h.ih$]5CJOJQJ^JaJh$]5CJOJQJ^JaJhB/5CJOJQJ^JaJ#h.ihy\5CJOJQJ^JaJ)h.ihy\B*CJOJQJ^JaJph h.ihy\CJOJQJ^JaJ h.ihCJOJQJ^JaJh^ACJOJQJ^JaJ#h.ih5CJOJQJ^JaJ%&&&c]]$IfkdH)$$Ifl40Vn* % @@ t0+644 lapyt.i&&&&c]]$Ifkd*$$Ifl40Vn* % @@ t0+644 lapyt.i&&' 'cZQ $IfgdrQ? $IfgdB/kd*$$Ifl40Vn* % @@ t0+644 lapyt.i '!'G'Q(gaX $IfgdrQ?$Ifkd+$$Ifl0Vn*% @@ t0+644 lapyt.iQ(R(S()c]T $IfgdrQ?$Ifkdz,$$Ifl40Vn*`% @@ t0+644 lapytD9Q(R(^())))))))))*M*N*********+ + +++A++ͼͼꪙrr]r)h.ihy\B*CJOJQJ^JaJph#h.ihy\5CJOJQJ^JaJ)h.ihB*CJOJQJ^JaJph h.ihCJOJQJ^JaJ#h.ih5CJOJQJ^JaJ h$]h$]CJOJQJ^JaJh$]CJOJQJ^JaJh$]5CJOJQJ^JaJ)h.ih$]B*CJOJQJ^JaJph))))c]T $IfgdrQ?$IfkdN-$$Ifl40Vn* % @@ t0+644 lapytD9))))c]]$Ifkd".$$Ifl40Vn* % @@ t0+644 lapytD9)))M*c]]$Ifkd.$$Ifl4'0Vn*`% @@ t0+644 lapytD9M*N*O**c]]$Ifkd/$$Ifl4%0Vn* % @@ t0+644 lapytD9****c]]$Ifkd0$$Ifl4%0Vn* % @@ t0+644 lapytD9*** +c]]$Ifkd`1$$Ifl4%0Vn* % @@ t0+644 lapytD9 + +++gaa$Ifkd.2$$Ifl0Vn*% @@ t0+644 lapytD9++++++ , , ,2,d,e,,,,,,---......3/4/?/@/Y///ȶڤ~p~~~~~Ȥ_ h.ihCJOJQJ^JaJh^ACJOJQJ^JaJ)h.ihVB*CJOJQJ^JaJph h.ihVCJOJQJ^JaJ#h.ihV5CJOJQJ^JaJ#h.ihy\5CJOJQJ^JaJ#h.ih5CJOJQJ^JaJ)h.ihy\B*CJOJQJ^JaJph h.ihy\CJOJQJ^JaJ +++ ,gaX $IfgdrQ?$Ifkd2$$Ifl0Vn*% @@ t0+644 lapytD9 , ,&,d,gaa$Ifkd3$$Ifl0Vn*% @@ t0+644 lapytD9d,e,f,,c]]$Ifkdz4$$Ifl4K0Vn*`% @@ t0+644 lapytD9,,,-c]]$IfkdH5$$Ifl4K0Vn* % @@ t0+644 lapytD9---.c]]$Ifkd6$$Ifl4'0Vn*`% @@ t0+644 lapytD9....c]]$Ifkd6$$Ifl4%0Vn* % @@ t0+644 lapytD9...3/c]]$Ifkd7$$Ifl4%0Vn* % @@ t0+644 lapytD93/4/@//c]]$Ifkd8$$Ifl4%0Vn* % @@ t0+644 lapytD9///*1gaa$IfkdN9$$Ifl0Vn*% @@ t0+644 lapytD9///0)1*1+1,1h1021222222<3=3y3|33333Ƕǡ؏ǡllZF&hB/h 5>*CJOJQJ^JaJ#hfB*CJOJQJ^JaJph)h.ih B*CJOJQJ^JaJphh^ACJOJQJ^JaJ#h.ih 5CJOJQJ^JaJ)h.ihVB*CJOJQJ^JaJph h.ih CJOJQJ^JaJ h.ihVCJOJQJ^JaJ#h.ihV5CJOJQJ^JaJ)h.ihB*CJOJQJ^JaJph*1+1,112c]]$Ifkd:$$Ifl4K0Vn*`% @@ t0+644 lapytD91222E2<3c]]$Ifkd:$$Ifl4K0Vn* % @@ t0+644 lapytD9<3=3>33c]]$Ifkd;$$Ifl4K0Vn*`% @@ t0+644 lapytD93333N4466d6caaaaaaakdz<$$Ifl4K0Vn* % @@ t0+644 lapytD9333N4O4~44444445555666?6c6d6ɶޡޡހo hB/hI5CJOJQJ^JaJhGagCJOJQJ^JaJ$hB/hrQ?0JCJOJQJ^JaJ)jhB/hrQ?CJOJQJU^JaJ$hB/h 0JCJOJQJ^JaJ)jhB/h CJOJQJU^JaJ hB/hrQ?CJOJQJ^JaJ hB/h CJOJQJ^JaJ21h:pf. A!"#$% F17 {k[5#=JFIFC     C  L" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?((((((((((((((((((((((((((((((((((o|f1 ͐!uOr2r¾]~_mשs|Λ:N-hxdMUK95t$[_^GtWƟ>+m?߰7|Wu7 u/?}E|i3&gMGS u/?}E|i3&gMGS u/?}E|i3&gMGS u/?}E|i3&3?EG=Wokiւd :T~"NU*a*(n.-[zK8ZXӧ&JjZ>+>(((((((((((((( (`Ҙk oIpx>#-'Q[;/9I cT*AvZ>>(? fu/g|*Q1r{{vҏ. ƺvjM'1Z?㌽f%exi+rgW1iF5_Q߁V㯇>uo ҉08 `^;Wi'ße;d9X{oᏁ7R=Mi$խzd:{ gHrxwc\CN.rqZ62_3.8f|"b$֋4_%G<_~> Go~׵vR5 ]LcC m3Mywr~=ߴ7wu .]ZMLJmH;BJGe@'l)C=X5wV815C߇CY~xPn$}7 =ǞqXi%jF)TvK(%Gcۧ`hV[9N~זתB_ buMY?ٵ*s)` ~@_-'Z/,4kM]N7)"Hg澵?2hKzҭl,t6 q)'wH7ݎzר5^F}_xP[4j#eH8i$l}8+ 9b\RzNWմMY+ćb08U&ְQ,}IO SO߲[/Ys,ڦkY!#D%Ysy>W,v?bM+w۫3pbj |IYx?ul LWv7zsW[+1U%?f5/3SɸԴ̂h[3hS?g$K{漭}-}ֿŗx\fGqEo4 =|emK ylt:ƝlxZ8iT?S xocOě}x,2c[D+\WT?S x~߳s#=WNy;JA+$8$WeVZl-9Mκ\PO['?qXvr)|x~|?Wo=42fFh)}~rZEg ~^ KGG 7+$uz@f_Ϸ|^#0vIwUHv]b+7i+xGGVŧ7v7RI0&RdDY8?E}wparru)EB\M;$5j|_F[sL6cR1^ny䢵M]n[u?_ï' ˺-ݖjs̙d} RƽYoG\/[Ge n`S3L~FeOڃ?~ K&Al;+th Krpq^SXbٷZ_¿:/<+}k[]̰q^ rGJ:pyޥI^۸ZT{R\뫊Ӫ??ட~kUXwZĺmz}{vqГRO ?M!?o/\k"ּ;jQI'34`UQ7E_mogux2%$x*·@sh~0|zm♚6 J@l0\6Yնۅ=lIIuz~qI1x좔cRqӕ-SS _gω)>a;\[tϗ6:֯)e;=;S@E_Dٲg\`g2/~|!Ěyĺ Z#Oyo*8FsB_<+_]-G}i+t<9LjE8uM(EY(U%;^5~cգ᳚tjUnsJIJOj_F}-IL%h+hZJ12n ѲA?'/U$ҔWv40pWwj2S}>SSRIY9B2iodz5à?mVPj_G: Fg5q3Wȟ5à?mVPj_G: Fg5\AAud?~*?._: Fg4à?mVPj__JQGWOWȟ5à?mVPj_G: Fg5\AAud?~*?._: Fg5 #֙+k]7\Ѯƛ| @ 6'e={+ިg)OQӜiSQN:It8&٧mQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEW~+~͟>9𶗭j~+;VILoi*e 16WV_|#|@nOY7Zg-ZA4f7_X֣CNhs2NQi'\uJtg7%ѵ=O? 'gmo$/xk[ $>Y$EDb'=qU?g|K~%'>&ڰż $sHd#ٹ8+GO_ÿE-m ^5*01 53Eoϭ~͞ h/mK^m"̶1#U;_?t 8,4VRNaգMRm-T)I.XӤӮ*FJKWwQ^SkIO׬{ XiҕvNX]?voW?N|Os{giX-;YU܄ú%|6x_ZX^mkPӵd5RߺP͗'|0j(1~־м?>vk{>iYDYvQ_@~jZ_sCҼ7uw|X0It&HAsd`JjQ&[mem; |O<3:hbihR^r|)1e)J9N1r*(4Msiu$w8slAJ1kpg4-̬}%h/8.Gq-/VI ?bu3 p|i_x|3y#`9u[?`GlvWai:WP7F%X AZ~ !'amէ[%=6;P H䜏+丌|]+ /jPPTqwZ.ǭ>kF޶9FsMIY褢sx T~hSXڅv#ˤEܜW⏌_ ?0z>q ^}CܲbHf I,1c{o(\~?W\>>nPKt:ifiC.>ьq6+׏a+c#C-T I(g{tX8G_BIӫ8IIF{9_uk5mw>޺wC_>5ƞ-Klۃ*IBqs_PI +,'n3c'rO6~|oaa\k<;rw1;kBz>:|_mB|A-NJMR`SYl JE*B|+qSKGIsB*S؅vm.}P`16^/msײ|z'Q_Q@Q@W~"l_ڣwtF_X+RvmKv}E|ul~_/k,Xiz,Ycd%K!d2gj_C^2PhwG' k? ی|enR¬B E8;>[/άݖaҜd4ԹS^Ӛ˧+WzTxY??Z?KhV4I@mȑE{pqWV> ?k/7IG-DR|[g+BVO*A_@S`;9i乗:ԥOPO6Ҵ[vDSy*3JjrFpms4wIkի o?/kIu;D鮲p#'FvE$33P|^df|XxKRKyAGlЎ4ִ`hI[~[-mױL*)-yrnmtK{ /&?iC&O4VI|2mU0@k/Z⏂ 7/Qu}r,[F $1]|㋩u%OIJ -5ė{tE %PNeg%f }֧UE|Kj/O NMpm<]Ƌ4%vC 1zH*弶o@'~ x _gI-Gybs??(&qy3F2(QjRҳ⓳ifև60xҍӋu;Vi4zEy@ |wb8Ƙ[yU4݁|B kGChmAj2,<'wiwӖ@ʼdcXt>S$y%gvWQu_iK|./ 9i+2G),Sh 9V_}@T`o_ad'VYx&0ad)SAȭyZRS&֭i]RM3ܮ4'RXJMFpn=dOiyHQ^?f_tX%45ѣ}֑`G19r8~2~ݿ?hߎ:N#bdi\e'D bg#9=o_Г{k3lSA{;s^q\ۛ]/=nM/k5go[3@,̣8=~߲gí[c AԮEp#'8Q`85>a/gt)ϛQ哋Mr-ggtgJHq}m}ՙZϿ,~*Mb‘7c" b#?:юO8|l%>.5M5BjƍƠ&RY$9\qE՟@W?v*xs5aU&07ʅqc s^~~:oK?OMy OI6),|v~\gҎ>uBӋSTVm|*)괲zg[JYRRQnI?ɭkCg; ~W|IixJm7hMʭrZ= +?RIGF\sGiB(0q+|%Gı~ݿ<Ԛ-t{p#lgB z >4ړá5ŗni6|ܬ7I QeV*;FiTn.QVFs hWt%YjgoT| ែ 4? Mr@'!Qlq$㊽o>?| HI6 q aѶ 0 9oC?^ ⦗h}4l%w%" 6P'Ik~Ug4j;j6 !WQa+ax &ߴwuC5),4ISVeS?<| /]0k]28ZFQ W64-E𮵧^Kpmne <~,̳,,kS\My+;urYiv Vg帨`ДF<4$](Tz !Yok~4_SWk+¨GVwj['']/W\~eǻö̙ oPW$ ),.uK u4nQI46g)ZIΛi^.Mtݴd=B(,((1_?7?i_Oyz.]🊵+wn (F*]X7kn7ď Fܶޗ jޡeV+\> _ J+q|ђm5Vi 8qFV2R\IwMu>hأDEMce4f9u&+s׭v3|Ň__Wzg x.Iöl.%mgf w% _g?cW$Х.UNRW%K~<7\VxwċhI瓞|mG5K:H-o0@ nC\cҸeuW'5J4拌\cP֪:Ik[iG<5 Pu]Dd%)JN3d(I=.~C3S_GچMg-fY_Q~ql8(}ϻڿZf7?ؓU?Ÿ:n7d֮ӬZɣO?2į5gggYŧok0TUW/%<i8^n puw}᪙e9US(ٯu'}[4r_o?~7RxV^,^5 wK1))"u]dF!S -4_c7╉/$io10r Ns8{3K]?oYn[MoK ޻eV* ([?xO J7I෷#ij89Z2RͥB_X/2R\劋irEZRmGقj1˛xK&d&㧙[Lhg`VNo5 وNfKXRcnQC~1nMo^Ԯ,K[Y/mRCSeU7c?+A¯ v[CnsKsWxH+Mƴn-~}jŴ)^Nj* Rs2i%m9R[^1'77ŨI&޺6O>z.mt{-ڑO<5e lБ׽x?߳}u8c{xԙ`Q_}©_+Vݿwfw|^zկ@ 5?jieԿE#ʎM0xF#=J%i|*#chGFMrN&|vsFEQnI M%ͥrXm RyQ@dpzWSM/{wYf=]5S̚m&T4i6gZNB/o}MSo? öm&6:Y`=c{6|uYRnӣ$Rko;MN*^/Ty+l~sAo|)%~lD>= ]Ew=mB4+D! ? ɭx+ _ ~0Xe"]`I~uv-,@*3pI~| G&3MG]ZjR&d/| )#W_^PׇA$y@$z Z0sӔN<(r>ͧ 8hy$OMu~..#ԗNB9>GoɨgiwV,(L[8cWo_I j^4M'E]i:5ϗUmFK ֭VJ*6U^&.{4W,>uF(UiՔ%%iݧeh]6-_aKIe\jz]i8uK$r(VS&8ڻkUx)bI4.U3 ʇL##Au뿳w7|Mz+ Mpdh쓉p~M9?c9N~$'rtk]}y8ZW8'EGz;_ }?Zɋ\љk1%f%:['$^^_g_*hn|ͦIj٢E+drvJ=>s#HCm,i;i+w|D><𖙭ek`r:}8rTkE+59sEQRJ;٭9_KԒQʌq~,'잗OV߃^W k£NNCO5Ic5R#0O}&FO|2~ K}ٷX1MB|'۹s)[ٜ.wq_> ~ῇ t9Xh|V=NW'YGGj^!?+Fɬ_=m_+n2CXxƥ 8St=$+O앬sÒR^*uu?q_E̚Vwm>?`?h–> ^ks,b ٞDq*0zW=?\oEu? Oj 9)r@2XyɌq?3;7.|;xgl׃S#t3[ʰEihXF0{~|/]ŷ?c̻BY"Uyx *PNG  IHDRZɺsRGBgAMA a pHYs!! IDATx^^յ XB[{n q# ݵ@8A"3d&23d}ow`Ÿd>zrED򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeD򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeD򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeD򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeD򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeD򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeDxYPB$-UVk+Ɩ['ڇmasuci}yΉ% JW{F{:e2~z'VnBfe'"yDDlV;9CGofax*_ZMz*޵?Κ>NnV۠ə߼ȎKShɹkNZ%03Uvkz;S׃_p_Ymb^,Z,+_ܷWLOj;zl螥T t]cx4)}Zd4L^o8yuV/c(L9 #(a#W.>&n;mG[}6sKmYkt}'fms6گ>yldNzdEŲ<6YMSsB> "yDDDh_i*:rWou 6m_ܻϓc?w-Qڥ4$} zQ;rT1gK/D3XφMcG؂W>%v[׳T߲POi" cw/fn2֪F; !bme8>u;{7Z5Zmz+ۺ\>u\ţSzObE;IF$5:!}pf詯jo ǟNZn[7{rtm $ﯵ^7z -g,ι!{KߵMR[$\5K'A )dt޴>s<="nU~6BQ7+zb$*g3!=Oȅ[ +V>"[q?Hx( hVۂU:6Y:'4qgٍsvY#]!yBk;wL ]YV#W@f u+D$iIi D.vs?(W)޿ޖlՐe&<.p՟gDeg-ޡV6JNɣΝYMK#"eΆ2!אYhԅevCvkDhhl8Mŝ\4C}sqc% nZ~sgMwXE]WrQG ;f‘}l=" Wlz#l hvu0 a}E6oKK# p-ذN?H35  Yu~vzYuPdU!!HRdP~_Wo^j۫?fM_>"q |8HjoՇs")kí6_vȣ6Z/GLZ" wE/^B@#섃CP#X ~kZwp!D&ɤtKlZ׶NKb׬uҼI+lg5A'-4v&mݿdczd7B*A.9Ic m֎r0BbK)ʄIVTܵjzBk!ߤt,Dn}@&4%đ_e;5BZ-hW2,B/7Ml5<"""^:<$\}Vb+}+mG B5 $\(2F?*0R8o0e-0T{<%tjV#F \ߵvص|6zzkPKiܯa2YIJ-ɿc0|bL|]BbjL<`mIcg@td~U,?>vC/^R>򕔕 椩EɎF+\mO'VV'*l6sV"gmƗZo>T#""EᇭOpoD&Þ^oh@O9QHXJ&Z3B}&Z ;Saȣ1,ODs'AfOusK۬"d[M6 |فn{l,BWOw nj5ԃJ[j; t`$$eN<r{%vBoVkV< %ioO^ +Xn~,Kf͵w\<1qśoXaZr[]Y+_u<%yBG$#4pEƖٵͬrF6nIH׷̟/ED ل\.-[SB7! 8V{{=j4wĿԊdacBmek7BW2Q(-K-2=)kHTJgE!9w49Vd}Er\/۞EX],WPYc8;w})&DүfFH|#.ՍxVi ̵ݱ[\#7!3nH[ 8³WkBy0fϓ7ng{Sa**6!Qb_vO9M^G qP-n8w}õ}ś"d`rT>w"[Z4xg < Isi_(NVB@ dM~mk"@X|:dScFZ_ =NyK4@~b]]hxtR;Ô@i9“URP!kng#N#$eft]YÚ|x!C?iH9>qϼf< m͵µ /> Ľ!Qnge|vQP_ŽB_ Jf]\Uř!ȃ@݂yH6@<mm%V );X %eݾ"{< zCeG$Oœ zr ˣ8cy&q,<"""^tf ssͲ;4gAf8f}侕Z-+'rt!{Mcyuc[dӖd+>/ݫcG#h .cz 4]򤹺ij۽ m]v>]߷`C׫*ꝴ4)$%wz r>pB}w8Ȋ+, 1O'*6s]RirU գE!=&e8<Ib1Z/GjG)smSU =_=%V<`_~}ٶ6  0WBXθeKmuE-Y!" i s.}`OWoYb@F(gx K̲+i>(Qd&?{yb%@II"9?zͪDdo%VV(/ʤ+d2 UVPmroXbˮ~>$rh dϐi濷{}u}t&#yDDDd8w ˵#ܧ7Xc :& >"i}eN:[SkCWh]T mv9>w$Y7{:\˹8GX~ں~~=Pqb4܇<agI ʷ 4H[ 9V|e +HKĬ`~;f4sBm6􉵶Aq}߷"-0&y+n1?2u-vŔ$,H]3עx!|jhyDDD8֫FS+$ H7Lmvaz{Ո\竷̱V?$)_:GD mzD"iU8.P0  +u̶kْ3 y1 #6C:B ѿD''>n.l$4[e`>r˜B#a랺̼ _yyA1{8p}+({3X&A0c2Mš߁>+-3>XE/;r" i6fFD'֐D"gml}^k6g.4{}^cnc6wewfS7F q$y$ X*p~cSe&A{hʎ`S߉wXf,c+Շ|(O!*A.SFLY;gi*+?°ՈB?5GDDKÐ"_`2:u ~Mߓ|k2tD5R ޸~*kUSGx&@u{]F}K+= ;<Җw8Oxr8DM{v ;vL1zΙiǍmǏη?P$OF JkaS?(CBQH,v%UE[l'$ "Q$Vm|%sDlJT| uG΄y$ <&WWev@B>ovݯ׻oW,_Vg^PdJO#кu-Wf{`][-Ѹ`M}'-V %lN&ˑa 0B{NJ9h𮅲J%>CM"^g1,y=FLYc|gXQvY;jt o6LrGy ϙӬ{͘9[٤E$Xw"|(3ӭ 7.yȊ1sQ&8a0soԖnp?3 FbA v6&d Oѣ mSkA<ЧIA$ CB!<۬ )#~uM &0Bz|!'~}b^լ|S.a2fgKv5.#k]IyĻytyz\>( }.X 22J?A;JCYݥgȃ_#""Eg!!-ze3rAؓȃsuvX ρ wZ cJ욢>{7m,e2G \bRŁMZc凜ͰsHwvq5ٸ'Vؑ @% UJ| ɷz Cv"J`S$cL?`}R(,e+_LZ.YT$6{,,Co [KV<"""^J4ةg[Dݠ mʊЗC$@sAAd.hL#4JHuV^א! xYU!MX0<[o^sF9J,f[SlkGV؏Zb_~};\m+*m[u,,wLQIV{T,E^{}N~}.6&N2}ԍq*""%х/{5Z-2o' ":_#\rCmZ{DvK@g"X̊ ~Hӷ'L j`azmi 1P?}46ɟl0='|# BዾnGb虡@82!F~~&=}8N&*̃Xeo'/i*Dx]I&I k"ʺF V{o)I%w+>4 M m-vv"9l3tc^ s,H/:$ q4F؍;P;M5ڙ7u<0";Ґ w{3! ԄDJJQgǟrs[K+ԉ2HB'䪆&z7a8v GB~_J}EV|A8SؾLc2㾅 3Kg KU o㠬`!Gт:_&l|)3aJl<' θiQ2wE疡,'WqQ(#[EDDHȃ9eVFFe)Bͮ]aGB0/˃yiY}i'Z}3!B Hݵ`,wM(+++a&?kݶ,Yzr`5~ CD$" N57 1#Wu0^J6M wҩy(X(wu_Be*@lt̗"Cvyy"K#""E!GLY|6>yB+r@L+~/5B_ 0qo6¹v ƒM.2!!*<Lnۗ^/!0OYBpfk[.`8mJBnud:q$CX|53l=$$'!d]W[EDD@p#d0O–Yiջ?ono/޲784d8\d2Hʷݷ6* QC}0fkji/߲Э> cxGh˟zk d?m{hӦ'FV["X%<^7z-QX܅O/Azw}σ .˳5*V] !x8>GB: 2IһZ컷γcG3_L^$m8bknbyYdڪ@!9t_[.d(>l@PKf2W>>F m{TIX0C{ć kE(:q}i# t\#ch}m_'w!rȤC`,o>5c {hI:a?̼\@HOolɫjM(#`5~dOG)#FDD??wbNG̳?<֦,=r{-o^]sn>zC?l*,X>²NJ͝Ea6.,ءwPa*U`uZe9䬯fmל04;nLJCo3$sJgj]_6}~٤_q2vy\'̍ ez⭲u g}XJ/hτu1>[m7OmnʦinMm;tQ,Yllj|Of>2AW,?h"FIc s g_a8N[*Wl'+S|5\BTvescrsfʕcԎ[f'm'c?@಴@ئ-D l;bTW8J9 OaILwHxM*_6׾} cl96O^kl=޾uBY<3sdU*+ Y`ߍڜ0|D򈈈d:?JtCg a)˄sn|| Lf>BD`ʢ1#EʝŹr!M29[Q=]&"!,,>?s zg4{t T6[+<@<= _Bڗly&iR~ ~^V׽e1NJ /53HiAs\;zx YfDRGt1*' ʠ| %ϙa@@<"""'t;u\0PEػLc?sbH4c60l% CI'-'C1`OC’ϣ |'0!˻CdT~$ȓOL(82I#I; ok(><ǭ(|CRDl= EyG%r"}8Rqx̉Raz)['d( s@$$$N:_+>7GDDK ;}؊aUPN&laͽ^*kH&Kt!=s y, ~ SD;Ca6F?VCb$~bx!0Yׅ |rV<7; OG򸇋(Ϲ[CU0*n݇H(gaq$?Iʋqxw<>E() =u˜@8;>.+7)l!MG{zF*mJ\ ?L~.~i̊8oip${̳3>\quxW5G!pb!%<< 4gpBv!cpχ;"Hٍ;4X=iy#"Hy@qA{?VHO:u.tKs6\:"ytCA4C;FDs淋̗;i }SyK[:pcg~9`tWNc::K#_E#;:p?}/pD!pFtH ݹ+ srB߁?ܿt{?O>2,x8 577n~رcmڵ/j[755ٍ7?qٖ-[wKxͳYfٳ~zkmm#H 4TTTݻX^^nvja"ݪgg ;Ww@y_jGq?A۷o߳pWSS垎cp;Nmmm!rի]ﲢtď{{cs툷+m6{n't׾6p@ۻw?ၮ "yt3II?38۾/W3fܹYq{W?ŋ;/5!%=!?g=zpuEx_Ŏ;sK۟9;}6m \:Cv(xw!~[ֳ⇼y7olG}tGX/~ .эAGMozӳ46c=֡@Bihi+ ݹ:#` qO8d?K= 1̙3N뮻\O_b_,mtgikƎ?gf{衇\P#u׼YA֭눇c˾O?{>{;,~û!\u{緿gş<@gfpӦMvvջwoo~ODgy. er=}ݝɣFNH?] ~WxE +{ }LArrrlذaO~҅./8`y@|a~{Cƍ_zG\>}8Bp7; n;ҀK+Eyg.;مa.# [n{7VȃzM˻F8<~_wN+tp.7pRɣ,:H Bhȡqӑ҂ˣ3^x7Fw8AZc~;9B {ի^k_H~s_: @K'Ol~;0qO9gN訧}ڏc ΐpVi8.KٽΞ<6Cipjvx0X,1j(=zW)=! _)эAcLGpA0uuua+lxGGw?y@Yg#p > 4  H'#K'/_~yeկ~YZ.R>Zp&Ms9ʎ Hp}ݙ=ly_8 :#yd#OxvL~X eYxpA:,< r8ٻ<1hٖG <bR=tA 3\|x/c5K Ѹ}Q2e-_Yq իWO?mO=@&ҋ<!} G<t?@ 0 <.#7vG&kx JBڰ [v;OLz>~/>y+B .ydi-ϟcrj$δ_ȣ9acIܖ0p;4iHp/J1c&_dɒ@G p$H4@w\A(c׼BFNg}b}{ķv}}1BG q{> # pF8ӟo|YgS}^סO< M t=aNXyD;~YAtꩧzڱJcYkHsg>~q*  u| ,].mO P .ܩ#y(cK3/~.dBZӻj*w۱e@7d'g?YGɃ\|^waǑ#Gz4 y y>ܰfXf2}6l: i-OG:iK7wŊ|/K/7N?to+ӟNBaIVцBB% ^J@$n b`3G-B*M _(y fΜcV5kt4 G6=x:gm'|rG8o"pvi#|:0S:-txP yffi{<8G?юps3qD e~QGxabU@D(̇Ӛv` ,5q"YZ~<Gh.G1 մwV*x/ψ)b_җ|F@+e 9!LTVVf:׿ޮ*0)bYY7=vs[vH4AEHy/| *@YGR] :h!:Nn>n.p9NLg-:}?d2偟#ewq}xVh $'GuFHC<1~t!aP@a4y0 7Ah^xwqa0~ OR]xF8!;E񡭳/X 0 p;<'tt^݇ tYCUd }@ja/{ !|€P򓟸 (a̡\~0޲e|&-/2"袋4_wu?aAi!őO'9HC>C a9#.qAXC3À 0ҋ>GC1 e50-9qěn3cwC$n ]y"LS pXhO4,4y0L NP fࠓ^z>Ҁ#Y&! :Ue'12b>d0=!.:d4y"ÄyH0f ;:w18 r  Ʌ '6¤63O< 4A |` i@K Zb.#mypD0&} .ܘ@r “HPO!+ cY8-&7ĄvD^iGy>@ԃ rD(H3z4i<JAX $+"ytcҖeƦj> E9AYpi|~3?h8!=t2оLaXci⁤ =Z^ Cx҂T41q@ 1^AHo6;9{!l&m2DЅ0(stz MP'Ek&O^Pf)9 GAa'-o?! CLBˍLy'~ss#h@6yH7CFMqҮCG/YqtK)CwpsN!X 3XW V1~@Y{c8ꊹ61{-W(BBZC:»81^:&Q S5u,M < !ʃ`y/G+G, 1P#^}7Ec#X(8.\7 }]ɣ=灀b#Ao46i: M.=)y'˸:& 40@h!ؙgqDp#HGHs47!F5ZH HkpC?|!7fB-# ԃA2aco '.(GN̈́5CUpGC0CۡÊG>7JDmG8 X!϶<&tZ i\ IPBd \bƆt;ᦏ <1htGtt&@3KQ<Apd7x+ǥɃpW[=";Q\t6* 0@#aتH,Xc@a_G+ׂ!ݐGz#ز#mQ2!<all#HdAV :#U]#myPy6mBar;ayvBz}!PftgDƠȃHGi"Hay#<^.Ab% &)[XLB>_x';ҏ`̶<^(yr&L‰ -s5z;h_e9_Op7@pӎ{!G7:<>:ctt8 5%t8$Ȥ!KuѰ!WV1!LXa:t Y!qA-vj`yP741_+h,`̶<H!wFvA1l m^ǽȃ6 7(Q?)԰ܜgHy CKu_.(V\1#ʟe)XP|~B~%!G71ghXa σci$CQN\z*CgDh0|Vf͗p(9s#8B6i{It \ȃ!X1W+iKgi!QRὐW:mQ#dŽGypq<DX@̱>*Bݐ {#dU* R#MYɃ2b !C|!t7H~q\ثI;#G7Aht ydOٍ^m?;%+.Ef(+{ 7XCU@ǒ,~p yqt:l't<)B# 1ƚ~3t{d^:\3#~7\@ 1F^W'1}/;+3Agp!\8ux΃ }3]:;=y6,pp. JA$nAFkg~xA\x3l]C08{ςK#p#\}vnga|t\'}/c}3 '.p81:y'/<"G7C4H_s 5Hឧe t<\wá3?3\vYi?K$½4ٳ@yp< :\pdwAo8Oy3!Nu#ptK8x(u6s^v չ3}*0#Ҩ%c:I{s#zjRT.i VkSu3v)ʁgdaYR#F}3 C{w+MI? 'i{ &-B<@ډWtQ2Hm*) i<ϒ2$Oϊ/{~<~^+ݎ<.\{f A\k7>",AƫЦn-ce|?" ҽA{HM>$Ӧx'q PwaϤ;rZZ+~<f"9OFM#p:7cUf +|x{S.*V!9=L;jD=7(PfIIDXrW[mB+$r@;;(-ߋ,VFԖQ^zn/y˴?қ~Z>nLگb;r wbjmBF䵳3̶)$ĕyK^D$9yg'$ru4ٛ힅6iߒVuUCztpCR(g-9x-hx> Hjq~E }r}9gIδǖٛΟcJoS]gvZ;oLUly' 9khSSXW/Ig_ ׷ٟ^o}X9v"(]pM]v&iva:))U^90Ծw[.<Ҧ= ;Wf~p:3zUhil[LԿ!烗چ[/*ZhsYEq3eւ&@aP;m @k>z@y̳;A_xu4@XdX"_Dq_]FCmoBkflOWjo`}EmT2bAr/N"nhy4Uä3HyjI}?t8s9+׎]bǟ]bǍ*K[7/5&=~,1y|{b^ib;C αoݶĖWyC}Fʊzs"oݲȖJ{'ri<]s}r;b 3,nSB'#%cG\ޖۗѣ $ ̎1ݎSlǍ.#{/,3߇bXã?S& [m5%v],VBzQ^@$%BB{kwζ7^XdWzzM( XSbdt;mtcOm N_fo=^J ~_\K^n0ˊ(Xm߽ujT<3z5Îk)7f7McyMI|UuDHI=?x=t c4Ż샗ʳ^CfcoYbm˶ĢmWy[mWuk2G}>^h37Vum:jf!v ^PeWSXVՔIOU׷_^k(;fo<\ |s>*V5:9^Ǟ]d_i]8}]S.(h}lB֚[~P˳˥{t`ʟ!,wҶK8,g/oz+TC̷7_d㧯`ZZڬ\foƃqVYJi<[lV[IV[J7j̭`"bxb^+Pc{HU|oKk)gN ڞ^-\*jL:x&ʦ'W( ն:Z/Օoڝsvd#j4cGYy4f؟\jKdynSZ˅3LKsUI;J(K7ո%V.[8{O[BBՍVr|r^r]뀗;IVj+ݬT3u)߬-{)&+ظLQ.rQB6Y_o>kKlvO՞VH>Gae"2W*UߤU7OOPX 4+Ue|){Ȭ"E4Y+w[}Yx"fIj6U)VjwMZ%G_l[R|v1w%_|(-5sʪ}oگ:gQIR[.7=m]U-Jip*DY*m( - v ;l#ǎ9~vB:nh6RƫvWR^]56w[\ejmz_\e-_%Y k״դuMQ &@^/b|z-pmchJ/GV[ayny>gyмC}Yq/6ܽЖvbȔ-uKaf%*mWη7UMvۜVL {CI+lεן3>~` ϳXc8^7N9}%YZܺr5~z2=u}%JC\}⚙6p;k)U7evy%ۣЮ (?5y{-Z{w.\8^wN";Y2Mgɮj;gZ5fۇXyiSWf5ѫwX`tzPۨBr+,Γڻ'J^m/-" T;Eil?=>yLɤUvwη7+o=g[YOO[UC>5 Dؕv?<>xBIܜ-=)j[3sI|lP/akʂj7M1%j mȣkRY̲O,Dp;﫴AO|\WKٛg0 hkԳW+ڢQmR~/-/߼>vpqv*{E1s%`0c}yN;>{\8wfBf^cw'kz]P͚P׭vǯ]dLq69mZKg❧YcUx)-˶Xɧ:aqa_rۭp~{s"{Ev:1#N*Y !j{,ChΪz2Y#[ϳk vY4n^VaQ9"W}vkH5<^=D9xTٕ12n*sJ^}v G/ֽB0N{B;ViGb=G,|QGW_SYW3f?^=Ў:ȵCK f{UOǎ.רL+*,}X`7P.>?L.XSvQ**GTqÊ%b;ZijsCƱsD n}Zd4اo\[/([vwȗO?jWw܈;Vy=(Oa|3EfX U32)j3Ҹbrds%7Yu}2/Kq=؎?{5:^;Vy%stb)H[nNiQz{ z?vL7zD0rMYSi$T2A][Ycoz aǩ̮.١QRPPEmI2:p-v¹HfftPzN0ۦ(g1}|?Hi-sr]Q?aIJ6(D GT??>F遼ɘqR80Lݨ}\S81ϫN#rEej[EzNj,)? i8eB70T ]]SQP~ i86jjnª i^SN = ljK)Ru m"y-Թ$P+Ss6Y"]B]|j-siٮ65ͷ" :Ō Pt"b۷ͳʶ]ٸ JO+^[i?[Jpobl[p5J&[쏏f[tB%Dn5+f[j2Jrɇ (?UrJ K +CW϶Ko_ܿJW`d=vh[-8Act)a~YV6ؕe[U\RC(>Wsv9Lػ.ey[+i=T=]Vjhהl29LaXṲ3wBhǏ'iT^U IC$TDw/(6qckgʙgȒzlNSwAT3Uv4܇ܿ`$Ms,u 3-eX7mθuU:{+_iP~pr;RDW WͶ[{;y̷JTvY/,<ʎUDh_?JaI=v;ym_?KUmYuy{_=*ϓ"2}ڙKN?oYd7iW~r K oSuɃ*?u&˵ډz,&{hD*ܮ+n7l)R mvU?q\ )_^# zu}F sI j_V!b瞎>&xa9BҫK'ce"kjkVkfMst@  +$HX{ ȃO~@)$.*GKHۗ)*/#5$ D+9[lΖj{tYg38+^+a*-_\uv[O8 |Y8Ņ[Jbncq3r{*YExB@J܃+ʕǃb턱DPG-KJ>_ΟAV4Pi_Rd9)vumK]H7:_*WM<j۴^n2Ҝ=Yz@ڽJOwL(GT[M`8^_2`TM_ZfCa=Ry+ua|lj=nbo?ۇ^{nN"Q :YȽz,6g{[57ocڱ3"FEۭߨmv93>' sEȴ/dGZZihzuTO" m;W(q,`=T6]2Ϧc^E/¹mv;!b~Ƹ:i+CK Y'JMTu;nWI3pa7_K8WX%>r/P.oE KEs >H8ͥx4YJȵn*(ܷZXa;(cn7, y=֨ggOh}D= C"Z glV{R}hHֶo\mw͕r2'MDj~VWT4*R(|VIiO_Ju/ ܙ6IyG1D+!\{Es#fYoi?6UmVi5%0`TM[]mI}EG" KlvP ' N9Ou.KWIt,vfM/^fvC>I__[tYvmhc )^>K[lח?Y28dY%°չËV m촍N( l"qH}箥z{f4;P?]`At8w+ 1/lJQ ،J#uUkT6mTj+acX, |TBu!VwVGTgtUYӳZߐ2/H^-&hR^a}+Ey:"[gVZ HeRuygΐ^Ҝzȑ?@<r|[aJCuK߯k1, f޶ZypcDVy9R"fz0C[}dkI E=EG'-)}pyMɃf2YZek}>6C5`c\&.YC񔯶9hda8s}tH,SmB/4%?ICX)՞go\#>Եc~HMq|R5SXsJ]UUiNq1R:grؑ3۷͑ΝEf04G§ص8kU}[H$H%IyLAzFҜՁ_5.  eHGO+&}`=l;+n3BȲ ;V[FűYljcuO7-EQmMvrG#׆֫/D4dCT[r0\n$.վp<{.|}ׅs-gu5 S;-kնSB\dKHʺ)bUk4_M~YC|9UdX/S9o/]/E ɮd#R+k:Y/) L6)6KECmlN؊LXr,^#7-٘k%@9LZg;TzE8mm"{2RArvV[!4+dHmb&_b%[5cXkRkP9ayod)?[}kb_.E]k35)-#))Ez8 1,|\?s+}DɜҠ䴩m%( aQ<\e9jkɧ~HYF֠vBׇIX&X5 _O#|rm6WGe' 7H4o>c{ex>+N>N|'ߣ:hK+{/Fv ;ٶ_Z,W=UftO5/ܸwyLP̷O^ ~Ujp̷]ɔ⏗ߋGwe-\Og%X'y<(*B}V埡:"SVoio:`(忏,j:^(?!ak`}^V A%B殷#RKmw]m&8fo lrl'k SW, ʨDɣV(sݼ`It߶6sv;FZ '+,)tȣE u0`}dg,]u@^k1'/nsf٥y[DS){喝+srNZDRjiٓ2af 'o޶$dA_F=֪NN,h̉"~O}/d*GH3VVqb g+ve2[SYcKQ| ȭelz'חرK {b Ŋ"(E̴'O[ysT6RBXv6e,`(wD٫傾tv ^ӎ]fa)jkϛe7R^#BY%WXN~:VVO]i-d))KW>"Cru"YɷV쮳]>׵/`y0NFNc_wN7O ,xt..ow\w~R{ҜX}iIϫ-}C ׻mvhv/Ys16lw8b jV;HۍLJCPyN 3'ka{by4YVn G'W[em63LB|PV'QzWn3V~=hZyvV$ekj:xڝT}Vm`7v!wW^{8V.)Kn=9`/wN+䤳z>R9V}jǠXݔ_!AP;ws"N[i`yTx_R)IZzR+ [mdCE{1+W{leŪ`L#Q|C&z=w;.}XoUtoSC:;V[DXM)DL.d{x,Wۗ[)@,Umx`UPIKl,}|Yj 1~Evmmf7Y,o]΋ilݞZ۶*;zx\;fm+ǭ̄@e{Z*|5D3ZŰMmvkNZ$I:$ǿ 7nXj?kOh}\gV90}$Rhe+xq,O^!ŹjWG/7ΕVNJ**dž<)N¥~'%}NbyڪNC [ Y%EDC[]`: 5-C<$TdrE{=.Yo?g\+ةSl+J)kWЇ]" il)̲G2C[wT=MV;/2Z?{K:=lbAJ<)>shSo8]ucwKY@葮]+FV  4YNXhEw4V(ݎSbq}R;z$5-"iIvwԑIJu+Di*Sayft~}w/=9w5y\WU,f/'B&mRz\P_m߹c{6=×߻Qdi`ϊ5BT]>SVdϢؘJht;bڣs,z2,exȎ]dlܩvVXcXcp"Qw7t94 Z>T0!2ظvZ%lePb=* irIv[Fu`|\q4L N,]igK\xsy]Ri"ROz.wNmsUf:ig>V,6I(3sNBe{\kb[[Ymǟ y6 LߤN{xhx^؉cۈ76)kϸeކҔ'TO4g]C=L> @Kî_ݻBy1T7Nɂa߿sk,\˃rda+VHAL+]o`l4æ* >8@u: >M s6>-Xj5G-N2nA`ް_OdI]Muquf) B:-jC6H}sG qiaՏ]؎P<M wX6)[eRcp)_b!KKHs.+;N' A5@a"i3K6g^(wnYb߽yvmT/j^c;zl]^R! ;OEmM,& f]Yݿn1;mSZ'Z}+슒F#T/PmooK+=ӆFpnͦ&UEaյC+6Y[ɖ2Ǔ-N˄ \KU6[}v:X& m}S~"-q}qÞ&eVk.5~* r,!.Nlתl@;ks |r=|hJ;p=6Hk%hEJ+ߣ㮛۶V+Mbz56*N^lCcnF:M!>6&U>޾vRm[*_߿ŶU%?\Km# 6߾)kOY&[iUMJ⸶T?&殷|\2n~*W'-+ "Iyp&l-v^[Sexzv B@yzg&_o N{SdWlom>Y銟6(9OJUEmT7;s#wgf2>'|CV׮z'!_uwYv7_uR^Zuf`^a~sHQQ;!2߃TG| }j] 7/p>TBi1qeܵ̾~|k즲]6HLo"0HC쮅W&nX`U1m*Dy_OY'{ۑ:"Q?Sy,c&8Z[-{TjǞW WMk5 ~B:&cd}is7\ V1{emZ_pSbd7*jfm#x2މVtn`_U(lckݾz׾ꕿMM>(:MJ!(_xڠ:o Wim?d 6%UW'٨U*al_K/..V6"Q_"T*.T)]>&B75=u"V $f+H1A(,Y5Bt֔>XYh*/?G¬mh׳fF Vݤ}i 4PBf ruy)ն6W{( v Uն?{P&4xfMV+4ZL̕N~>@ /KC_rlƺ7:o/-ߧv0$Geԫチ jWr,>,=UPx`l՞3P/ABuwd 04qY-|78}guT埴A&}N5YA\m9)m*چ$\ 9AZ6BL^yF2uy_3,ˈie[ހ"*tz]ZZ ;؆2b }M>Bi8~qf;Y^ju ~ '5cCi ތw? 4GyGxThG3Tx4Qu7zIB6:JbBp=//y/#IE# e,";4f!).ʀ%u>)8z|D>e]{Rl<ѿFX>JG}r-Ct!O5!sO <#sHC$—w%H;>vI;I3C8I L9AmI]( Py?C%Ju[Kʕt%s>|#ԟ m_CJUyk6OYB=ϸ&[OD<GXI&eCڹGzW_7i7"NE#C[py@-]H6*ȉwT77a||0ICx~bu!TGd\߽nn8́&#緒~/94?ɳJ>Vn4ճϒ73Ax/  nysM3po/gqUQyqNϐ"{B{xNY+BX/KHR"/_rL~R̳}G:'98'ȟKNI- yȃ]}LOu^mV 9wn8R9eu}vb;fdjX {%nFwpxJzu s6%Mγ7+soaAXz3E$4*LnWemS+lcrs+mzl"<ehYo;q$b4u-Г1 88`7V5eۭxS2/Z(/<"""ҤgA,aa _Zoc%3'yD< >V!J3iVjZyS,Z C"}MhQS!dYpẢ|W&"yDDD<'|< 6ZϘ`H]iB)1u `]$eK&EzB~9KPHbjW*D򈈈x$&'Qp@H~B$:qYr/9&_8y"GDDDDD#""""ˈeD򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeD򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeD򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeD򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeD򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeD򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeD򈈈2"yDDDDDt<"""""H]F$.#GDDDDD#""""ˈeD򈈈2"yDDDDDtfm IENDB`$$If!vh#v#v%:V l    tI}I}0+655%apI}I}yt.i$$If!vh#v#v%:V l4K @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4K @@ t0+6+55%apyt.i$$If!vh#v#v%:V l @@ t0+655%apyt.i$$If!vh#v#v%:V l @@ t0+655%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l @@ t0+655%apyt.i$$If!vh#v#v%:V l @@ t0+655%apyt.i$$If!vh#v#v%:V l @@ t0+655%apyt.i$$If!vh#v#v%:V l4K @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4K @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4e @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4d @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4d @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4' @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4% @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4% @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4% @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l @@ t0+6,55%apyt.i$$If!vh#v#v%:V l @@ t0+655%apyt.i$$If!vh#v#v%:V l @@ t0+6,55%apyt.i$$If!vh#v#v%:V l @@ t0+655%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4L @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4K @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4K @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4K @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4L @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4K @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4K @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4K @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l @@ t0+655%apyt.i$$If!vh#v#v%:V l4' @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4% @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4% @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4% @@ t0+6+55%apyt.i$$If!vh#v#v%:V l @@ t0+655%apyt.i$$If!vh#v#v%:V l @@ t0+655%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+55%apyt.i$$If!vh#v#v%:V l @@ t0+6,55%apyt.i$$If!vh#v#v%:V l4 @@ t0+6+,55%apytD9$$If!vh#v#v%:V l4 @@ t0+6+,55%apytD9$$If!vh#v#v%:V l4 @@ t0+6+,55%apytD9$$If!vh#v#v%:V l4' @@ t0+6+55%apytD9$$If!vh#v#v%:V l4% @@ t0+6+55%apytD9$$If!vh#v#v%:V l4% @@ t0+6+55%apytD9$$If!vh#v#v%:V l4% @@ t0+6+55%apytD9$$If!vh#v#v%:V l @@ t0+655%apytD9$$If!vh#v#v%:V l @@ t0+655%apytD9$$If!vh#v#v%:V l @@ t0+6,55%apytD9$$If!vh#v#v%:V l4K @@ t0+6+55%apytD9$$If!vh#v#v%:V l4K @@ t0+6+55%apytD9$$If!vh#v#v%:V l4' @@ t0+6+55%apytD9$$If!vh#v#v%:V l4% @@ t0+6+55%apytD9$$If!vh#v#v%:V l4% @@ t0+6+55%apytD9$$If!vh#v#v%:V l4% @@ t0+6+55%apytD9$$If!vh#v#v%:V l @@ t0+655%apytD9$$If!vh#v#v%:V l4K @@ t0+6+55%apytD9$$If!vh#v#v%:V l4K @@ t0+6+55%apytD9$$If!vh#v#v%:V l4K @@ t0+6+55%apytD9$$If!vh#v#v%:V l4K @@ t0+6+55%apytD9j 666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH nH sH tH 8`8 TQYNormal_HmH sH tH DA D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List DOD TQY CCG Subtitle56B*phOHOH TQY CCG Header5B*CJOJQJphODOD TQYCCG Main xx5B*CJph4"4 TQY0Header B#>o1> TQY0 Header CharOJPJQJ^J4 B4 TQY0Footer B#>oQ> TQY0 Footer CharOJPJQJ^J@`b@ TQY No Spacing_HmH sH tH FoqF TQYNo Spacing CharOJPJQJ^Jjj f Table Grid7:V0@ fMedium Shading 1 - Accent 1-:V0{{{{{j%@ jj jD{{{{jQ{{{{ O44(fdfd25\5\5\5\ph@ fLight Grid - Accent 1:V0OOOOOOjF@OOOOO j9OOOOOj;OOOO j.OOOOjDOOOOOjDOOOOO44(fdfdl5OJ$PJQJ$\^J5OJ$PJQJ$\^J5OJ$PJQJ$\^J5OJ$PJQJ$\^J6U`6 0 Hyperlink >*B*phPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] d.c XX %Q(+/3d6 &-8?JRX^fpu b \>l ;HuXho. P 7 m !"%%&& 'Q()))M*** ++ ,d,,-..3//*112<33d6!"#$%'()*+,./012345679:;<=>@ABCDEFGHIKLMNOPQSTUVWYZ[\]_`abcdeghijklmnoqrstN,~,,,--d.XX/XR$ {k[5#=974b$n8Z]NRd>x *m#@J(    A,?`"Vale of York NHS LogoPicture 1H:\Documents\Pictures\Vale of York NHS Logo.jpg#" ?  J3CA?"Picture 2#" ?B S  ?d.E#T6#E+T  X [  $ wV` ow)!!!"""g"s"t"""""".#6###&&&&@'K'''''H(R(5)A)`)f)))u****i+o+q+x+++,,..].c.f.f. 7 ; ,4,, !!$$**|+|+N,,,,,-......?.c.f..i%D9a=?rQ??@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !&'*Root Entry F K)Data H=1Table)WordDocument SummaryInformation(DocumentSummaryInformation8MsoDataStore Te KPe KNCYF1UWKWPQKYO==2 Te KPe KItem  PropertiesUCompObj r   F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q